Below are the most recent publications written about "Creatine Kinase, MB Form" by people in Profiles.
-
Kim IC, Song JE, Lee HJ, Park JH, Hyun M, Lee JY, Kim HA, Kwon YS, Park JS, Youn JC, Hwang J, Lee CH, Cho YK, Park HS, Yoon HJ, Nam CW, Han S, Hur SH, Eisen HJ, Kim H. The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019. J Korean Med Sci. 2020 Oct 12; 35(39):e349.
-
McMullin N, Lindsell CJ, Lei L, Mafi J, Jois-Bilowich P, Anantharaman V, Pollack CV, Hollander JE, Gibler WB, Hoekestra JW, Diercks D, Peacock WF. Outcomes associated with small changes in normal-range cardiac markers. Am J Emerg Med. 2011 Feb; 29(2):162-7.
-
Singer AJ, Thode HC, Green GB, Birkhahn R, Shapiro NI, Cairns C, Baumann BM, Aghababian R, Char D, Hollander JE. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea. Acad Emerg Med. 2009 Jun; 16(6):488-94.
-
Glauser J, Erickson J, Bhatt D, Lindsell C, Gibler B, Hoekstra J, Pollack C, Hollander J, Peacock WF. Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. Congest Heart Fail. 2007 May-Jun; 13(3):142-8.
-
Scharhag J, Herrmann M, Weissinger M, Herrmann W, Kindermann W. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease. Clin Res Cardiol. 2007 Apr; 96(4):218-26.
-
Brown AM, Sease KL, Robey JL, Shofer FS, Hollander JE. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. Ann Emerg Med. 2007 Feb; 49(2):153-63.
-
Storrow AB, Lindsell CJ, Han JH, Slovis CM, Miller KF, Gibler WB, Hoekstra JW, Peacock WF, Hollander JE, Pollack CV. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. Ann Emerg Med. 2006 Dec; 48(6):660-5.
-
Scharhag J, Urhausen A, Schneider G, Herrmann M, Schumacher K, Haschke M, Krieg A, Meyer T, Herrmann W, Kindermann W. Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes. Eur J Cardiovasc Prev Rehabil. 2006 Jun; 13(3):388-97.
-
Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006 Jan 3; 47(1):27-33.
-
Hollander JE, Sites FD, Pollack CV, Shofer FS. Lack of utility of telemetry monitoring for identification of cardiac death and life-threatening ventricular dysrhythmias in low-risk patients with chest pain. Ann Emerg Med. 2004 Jan; 43(1):71-6.